Organogenesis Holdings (ORGO) Return on Capital Employed Growth (1y) (2018 - 2026)
Organogenesis Holdings (ORGO) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,195.00 |
| 10 | Organogenesis Holdings | 327.80 Mn | 235.70 Mn | 11.46 Mn | 632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 632.00 |
| Dec 31, 2025 | 1,017.00 |
| Sep 30, 2025 | 136.00 |
| Jun 30, 2025 | -274.00 |
| Mar 31, 2025 | -916.00 |
| Dec 31, 2024 | -361.00 |
| Sep 30, 2024 | -948.00 |
| Jun 30, 2024 | -734.00 |
| Mar 31, 2024 | -159.00 |
| Dec 31, 2023 | -261.00 |
| Sep 30, 2023 | -307.00 |
| Jun 30, 2023 | -902.00 |
| Mar 31, 2023 | -1,150.00 |
| Dec 31, 2022 | -1,638.00 |
| Sep 30, 2022 | -1,719.00 |
| Jun 30, 2022 | -1,852.00 |
| Mar 31, 2022 | -727.00 |
| Dec 31, 2021 | 876.00 |
| Sep 30, 2021 | 2,426.00 |
| Jun 30, 2021 | 5,084.00 |